BellamyL, CasasJ-P, HingoraniAD, WilliamsDJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ, 2007; 335:974.
2.
KhanKS, WojdylaD, SayL, GülmezogluAM, Van LookPF. WHO analysis of causes of maternal death: A systematic review. Lancet, 2006; 367:1066–1074.
3.
MakrisA, ThorntonC, HennessyA. Postpartum hypertension and nonsteroidal analgesia. Am J Obstet Gynecol, 2004; 190:577–578.
4.
SibaiBM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol, 2012; 206:470–475.
5.
Al-SafiZ, ImudiaAN, FilettiLC, HobsonDT, Bahado-SinghRO, AwonugaAO. Delayed postpartum preeclampsia and eclampsia: Demographics, clinical course, and complications. Obstet Gynecol, 2011; 118:1102–1107.
6.
SmithGN, PudwellJ, SaadeGR. Impact of the New American Hypertension Guidelines on the prevalence of postpartum hypertension. Am J Perinatol, 2019; 36:440–442.
7.
TanL-K, SwietMD. The management of postpartum hypertension. BJOG Int J Obstet Gynaecol, 2002; 109:733–736.
American College of Obstetricians andGynecologists, Task Force on Hypertension inPregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol, 2013; 122:1122–1131.
10.
2017 Guideline for High Blood Pressure in Adults. American College of Cardiology. Available at: http%3a%2f%2fwww.acc.org%2flatest-in-cardiology%2ften-points-to-remember%2f2017%2f11%2f09%2f11%2f41%2f2017-guideline-for-high-blood-pressure-in-adults Accessed May20, 2020.
11.
ReddyM, RolnikDL, HarrisK, et al.Challenging the definition of hypertension in pregnancy: A retrospective cohort study. Am J Obstet Gynecol, 2020; 222:606.e1–606.e21.
12.
CooperWO, Hernandez-DiazS, ArbogastPG, et al.Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med, 2006; 354:2443–2451.
13.
SeelyEW, EckerJ. Clinical practice. Chronic hypertension in pregnancy [published correction appears in N Engl J Med. 2011 Oct, 27; 365(17):1650]. N Engl J Med, 2011; 365(17):439–446.
14.
HeckerA, HasanSH, NeumannF. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol (Copenh), 1980; 95:540–545.
15.
SassN, ItamotoCH, SilvaMP, TorloniMR, AtallahAN. Does sodium nitroprusside kill babies? A systematic review. Sao Paulo Med J Rev Paul Med, 2007; 125:108–111.
16.
YakoobMY, BatemanBT, HoE, et al.The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: A meta-analysis. Hypertens Dallas Tex 1979, 2013; 62:375–381.
17.
CollinsR, YusufS, PetoR. Overview of randomised trials of diuretics in pregnancy. Br Med J Clin Res Ed, 1985; 290:17–23.
18.
SharmaKJ, GreeneN, KilpatrickSJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial. Hypertens Pregnancy, 2017; 36:44–47.
19.
NewtonER, HaleTW. Drugs in breast milk. Clin Obstet Gynecol, 2015; 58:868–884.
20.
Interpregnancy Care—ACOG. Available at: https://www.acog.org/Clinical-Guidance-and-Publications/Obstetric-Care-Consensus-Series/Interpregnancy-Care?IsMobileSet=false Accessed December29, 2019.
21.
PodymowT, AugustP. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy, 2010; 29:294–300.
22.
GoelA, MaskiMR, BajracharyaS, et al.Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation, 2015; 132:1726–1733.
23.
BehrensI, BasitS, MelbyeM, et al.Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: Nationwide cohort study. BMJ, 2017; 358:j3078.
